Appointment of Stephen M. Deitsch as new Chief Financial Officer
April 04, 2024 11:43 ET
|
ORGANOX LIMITED
OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.
Latent TB Diagnostics Market Analysis and Forecasts 2023-2027: Insights into Emerging Technologies and Growth Opportunities - Fostering Strategic Decisions and Industry Leadership
February 27, 2024 03:58 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Latent TB Diagnostics Global Markets by Assay, by Risk Factor, and by Lab/Place. With Executive and Consultant Guides and Market Analysis and Forecasts...
ELISpot and FluoroSpot Assay Market Forecasted at $421 Million by 2028: FluoroSpot Assays Revolutionizing Multi-Analyte Detection, Creating Lucrative Business Opportunities
February 07, 2024 03:42 ET
|
Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "ELISpot and FluoroSpot Assay Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global ELISpot and...
LA&CCA Announces Collaborative Initiative with The University of Oxford for Scholarship Opportunity for Online Executive Diploma in Strategy & Innovation
January 25, 2024 20:00 ET
|
LA&CCA
LA&CCA offers Oxford scholarship for executives in strategy and innovation—apply by Feb 2.
Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing
January 23, 2024 07:00 ET
|
Oxford BioMedica plc
Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing Oxford, UK – 23 January 2024: On Wednesday 7 February, Oxford Biomedica, a quality and...
Tuberculosis Diagnostics Global Market Size and Share to Rise at a CAGR of ~5% by 2028 | DelveInsight
December 14, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Tuberculosis Diagnostics Global Market Size and Share to Rise at a CAGR of ~5% by 2028 | DelveInsight The rising incidence of tuberculosis and...
ELISpot and FluoroSpot Assay Market is Expected to Reach $421 million | MarketsandMarkets.
December 04, 2023 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 04, 2023 (GLOBE NEWSWIRE) -- ELISpot and FluoroSpot Assay market in terms of revenue was estimated to be worth $292 million in 2023 and is poised to reach $421 million by 2028, growing...
Oxford Biomedica to host webinar showcasing the TetraVecta™ system
September 07, 2023 07:00 ET
|
Oxford BioMedica plc
Oxford Biomedica to host webinar showcasing the TetraVectaTM system Oxford, UK – 07 September 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led...
Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board
September 06, 2023 03:00 ET
|
Nucleome Therapeutics
Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board Dr Greig brings more than 40 years of experience in the biopharmaceutical sectorExperienced Chair who has led...
Tuberculosis (TB) Diagnostics Market Size to Surpass USD 3.19 Billion by 2030, exhibiting a CAGR of 5.6%
August 14, 2023 06:40 ET
|
Fortune Business Insights
Pune, India, Aug. 14, 2023 (GLOBE NEWSWIRE) -- The global tuberculosis (TB) diagnostics market size was valued at USD 1.93 billion in 2022. The market is projected to grow from USD 2.17 billion in...